Rise in incidence of chronic diseases, increase in geriatric population and growth in acceptance of stem cell therapies are the major factors which drive the global market growth. WILMINGTON, Del. , Aug.
6, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, " Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033" . According to the report, the regenerative medicine market was valued at $32.1 billion in 2023, and is estimated to reach $531.
7 billion by 2033, growing at a CAGR of 32.4% from 2024 to 2033. Request Sample of the Report on Regenerative Medicine Market Forecast 2033 - https://www.
alliedmarketresearch.com/request-sample/391 Prime determinants of growth Rise in incidences of chronic diseases and increase in geriatric population are the major factors that drive the growth of the regenerative medicine market growth. However, high costs of treatment hinder the market growth.
Moreover, technological advancements and regulatory Support and funding offers remunerative opportunities for the expansion of the global regenerative medicine market. Report coverage & details Segment Highlights T.